Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interstitial lung abnormalities – current knowledge and future directions
G. Axelsson, Gunnar Guðmundsson
European Clinical Respiratory Journal (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Validation of the diagnostic yield and safety of transbronchial lung cryobiopsy in diagnosis of interstitial lung disease: a retrospective study from a single center in China
Rui Li, Qian Zhao, Shanshan Li, et al.
Research Square (Research Square) (2025)
Closed Access
Automated AI-based image analysis for quantification and prediction of interstitial lung disease in systemic sclerosis patients
Julien Guiot, Monique Henket, Fanny Gester, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Impact of Baseline Interstitial Lung Abnormalities on Pneumonitis Risk in Patients Receiving Immune Checkpoint Inhibitors for Non–Small-Cell Lung Cancer
Milena Petranović, Shaunagh McDermott, Sarah Mercaldo, et al.
Clinical Lung Cancer (2023) Vol. 24, Iss. 8, pp. 682-688.e5
Closed Access | Times Cited: 7
Automated Interstitial Lung Abnormality Probability Prediction at CT: A Stepwise Machine Learning Approach in the Boston Lung Cancer Study
Akinori Hata, Kota Aoyagi, Takuya Hino, et al.
Radiology (2024) Vol. 312, Iss. 3
Open Access | Times Cited: 2
Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer
Wakako Daido, Takeshi Masuda, Nobuki Imano, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6236-6236
Open Access | Times Cited: 9
Usefulness and performance evaluation of serum KL-6 and SP-A assays in healthy individuals and patients with interstitial lung disease
Eun‐Jung Cho, Jinyoung Hong, Jungwon Hyun, et al.
Clinical Biochemistry (2023) Vol. 118, pp. 110609-110609
Closed Access | Times Cited: 2
Prevalence and prognostic meaning of interstitial lung abnormalities in remote CT scans of patients with interstitial lung disease treated with antifibrotic therapy
Mireia Mullor, J.J. Arenas-Jiménez, A. Ureña Vacas, et al.
Radiología (English Edition) (2024) Vol. 66, pp. S10-S23
Closed Access
Interstitial Lung Abnormality: Narrative Review of the Approach to Diagnosis and Management
Zein Kattih, Brett C. Bade, Hiroto Hatabu, et al.
CHEST Journal (2024)
Closed Access
Prevalencia y significado pronóstico de las alteraciones pulmonares intersticiales precoces en TC de pacientes diagnosticados de enfermedad pulmonar intersticial tratados con antifibróticos
Mireia Mullor, J.J. Arenas-Jiménez, A. Ureña Vacas, et al.
Radiología (2023) Vol. 66, pp. S10-S23
Closed Access
How does the MESA Lung Study sharpen blurry edges in interstitial lung abnormalities?
Pierre‐Yves Brillet, Stéphane Tran Ba, Hilario Nunès
European Respiratory Journal (2023) Vol. 61, Iss. 6, pp. 2300397-2300397
Closed Access
Fatum Inexorabile: Do Monocytes Predict the Fate of Interstitial Lung Abnormalities?
Michael Kreuter, Toby M. Maher
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 205, Iss. 7, pp. 743-744
Open Access
Page 1

Scroll to top